Emagene.life partners with Adam Health to advance AI-driven men’s health monitoring and longevity tools
Emagene.life has partnered with Adam Health to deliver AI-assisted, biodata-driven men’s health and longevity solutions across Malaysia and Singapore, including distribution of a home-based male health sensor. The collaboration aims to enable earlier detection of health decline through measurable physiological signals.
AINEW PRODUCT LAUNCH
Editor
5/30/20261 min read
Emagene.life has entered a strategic partnership with Adam Health to develop and distribute AI-supported, data-driven men’s health and longevity solutions across Malaysia and Singapore. As part of the agreement, Emagene.life will also distribute Adam Health’s sensor in both markets.
The collaboration brings together Emagene.life’s functional medicine and AI-integrated health intelligence ecosystem with Adam Health’s men’s wellness platform. The combined offering is designed to support personalised approaches to male vitality, performance, recovery, and long-term health tracking through physiological data and biomarker analysis.
A core component of the partnership is the integration of multiple measurement and interpretation layers. These include functional medicine assessments, biodata tracking, and AI-assisted analysis powered by Avio Health technology, alongside Adam Health’s proprietary tools such as its sensor data and AndroAge™ scoring system. The AndroAge™ score consolidates physiological inputs into a single metric intended to track male vitality over time.
The Adam Health sensor focuses on measuring nocturnal erections, which the companies describe as an early indicator of cardiovascular, hormonal, and metabolic function. According to the release, changes in these patterns may signal underlying health issues before clinical symptoms become apparent. The data generated feeds into the AndroAge™ score, creating a longitudinal health tracking framework for users.
The partnership reflects a broader shift toward measurable, preventative approaches in men’s health, combining at-home diagnostics with AI-based interpretation to provide earlier insight into potential health decline and personalised intervention pathways.